Plasma zinc α2-glycoprotein levels are elevated in smokers and correlated with metabolic syndrome
- Resource Type
- Authors
- Kuo-Chin Huang; Jaw-Shiun Tsai; Bee-Horng Lue; Lee-Ming Chuang; Fei-Ran Guo; Su-Chiu Chen; Long-Teng Lee; Tai-Yuan Chiu; Ching-Yu Chen
- Source
- European Journal of Clinical Investigation. 45:452-459
- Subject
- Adult
Male
medicine.medical_specialty
Time Factors
Clinical Biochemistry
Biochemistry
Young Adult
Sex Factors
Adipokines
Internal medicine
medicine
Humans
Obesity
Risk factor
Nicotine dependence
Male gender
Plasma zinc
Aged
Dyslipidemias
Glycoproteins
Aged, 80 and over
Hypertriglyceridemia
Metabolic Syndrome
chemistry.chemical_classification
Chemistry
Smoking
A protein
Tobacco Use Disorder
General Medicine
Middle Aged
Overweight
medicine.disease
Independent factor
Endocrinology
Hyperglycemia
Hypertension
Regression Analysis
Female
Metabolic syndrome
Carrier Proteins
Glycoprotein
- Language
- ISSN
- 0014-2972
Background Smoking is a strong risk factor of metabolic syndrome. Zinc α2-glycoprotein (ZAG) is a protein involved in metabolic syndrome. This study aims to investigate the effect of smoking on plasma ZAG levels and its relations to metabolic syndrome. Materials and methods A group of 41 cigarette smokers and 47 non-smokers were enrolled. ZAG levels were measured to correlate to participants’ demographic and metabolic parameters. Results Plasma ZAG levels of smokers were higher than those of controls (P